Non-interventional Study With Pomalidomide (Imnovid®)

Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma

NCT03731832 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice

NCT02902900 ·Status: COMPLETED

Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma

NCT01712789 ·Status: COMPLETED ·Phase: PHASE3

Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT02176213 ·Status: COMPLETED ·Phase: PHASE2

Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma

NCT02011113 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

NCT02555839 ·Status: COMPLETED

A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study

NCT01311687 ·Status: COMPLETED ·Phase: PHASE3

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

NCT01722305 ·Status: COMPLETED ·Phase: PHASE1

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

NCT02726581 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

NCT05236621 ·Status: UNKNOWN ·Phase: PHASE3

INCB053914 and Pomalidomide With Dexamethasone for Relapsed and/or Refractory Multiple Myeloma

NCT04355039 ·Status: WITHDRAWN ·Phase: PHASE1

Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

NCT01432600 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma

NCT03023527 ·Status: TERMINATED ·Phase: PHASE1

Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT01497093 ·Status: COMPLETED ·Phase: PHASE1

Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide

NCT01794039 ·Status: COMPLETED ·Phase: PHASE2

A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.

NCT02612779 ·Status: COMPLETED ·Phase: PHASE2

Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma

NCT03143049 ·Status: UNKNOWN ·Phase: PHASE3

Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

NCT02103335 ·Status: COMPLETED ·Phase: PHASE1

Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma

NCT02548962 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Non-interventional Study of Lenalidomide / Dexamethasone as First Line Therapy in Patients With Multiple Myeloma

NCT02537808 ·Status: COMPLETED

Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex

NCT03180736 ·Status: COMPLETED ·Phase: PHASE3

Ixazomib + Pomalidomide + Dexamethasone In MM

NCT04094961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

NCT00911105 ·Status: COMPLETED

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)

NCT01575925 ·Status: COMPLETED ·Phase: PHASE1

Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)

NCT01745640 ·Status: COMPLETED ·Phase: PHASE2